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                                                        ABSTRACT 
            This study intended to assess the effectiveness of chlorhexidine 2% with 
transparent polyurethane (tegaderm) dressing on preventing infection and cost 
effectiveness among patient with central venous catheter from selected hospitals in 
Madurai. An experimental approach was used for this study. The design adopted for the 
study was Quasi Experimental post test only design. Purposive sampling technique was 
adopted for this study .The sample consisted of 60 patients, in that 30 were in 
Experimental group and 30 were in Control group. The experimental group was treated 
with 2% chlorhexidine with transparent polyurethane (tegaderm) dressing and the control 
group was treated with routine betadine dressing. Dressing was done once in a day for 
both the groups. The tool used for data collection procedure was MR VICTOR Tool for 
assessment of central venous catheter site infection. Both descriptive and inferential 
statistics were used for the analysis of data. The major findings were, Moderate infection 
rate was found in experimental group was 1(3.3%) on 3rd day, whereas in control group 
6(20%) had moderate infection. On the 6th day assessment showed only least 3 (10%) had 
moderate infection in experimental group, where as 10 (33.3%) had moderate infection in 
control group. The mean post test central venous catheter site infection score of 
experimental group for 6 days (0.56) was lower than the mean post central venous 
catheter site infection score of control group (0.73). The obtainer’s’ value of (2.86) in 
experimental group was lower than the obtained‘t’ value of control group (3.91), which 
was significant at 0.05 levels. The 2% chlorhexidine with transparent polyurethane 
(tegaderm) dressing found to be effective in reducing the central venous catheter site 
infection when compared to betadine gauze dressing. Transparent dressing 
(Rs.129.50/day) was costly when compared to betadine gauze dressing (Rs.80.50/day). 
 
  
 
    
CHAPTER –  
INTRODUCTION 
                                       BACKGROUND OF THE STUDY 
                          “A life isn’t significant except for its impact on other lives” 
          Central venous catheters are commonly used modality in the Medical Intensive 
Care Unit (MICU), Intensive Respiratory Care Unit (IRCU), Cardiac Care Unit (CCU) 
and Cardio Thoracic Intensive Unit (CTCU), serving a vital role in the management of 
critically ill patients. These devices involve placement of a large – bore catheter into one 
of the body’s main central vein.       [Vanderbilt Medical Centre, 2008] 
            Patients who had a CVC on admission or inserted during their stay on the 
general medical service in a public teaching hospital, November 15, 2004, to March 31, 
2005.They identified 106 CVCs, 52 were present on admission and 54 were inserted; 
there were 682 catheter-days. The primary bloodstream infection rate was 4.4 per 1000 
catheter-days (95% CI: 0.9-13): highest for catheters inserted in the emergency 
department compared with those inserted on other units (24 vs. 1.7 per 1000 catheter-
days), p=0.45.       ( Trick et al., 2006) 
            Insertion of a central venous catheter (CVC) is a common procedure; the 
prevalence is about 6% of the hospitalized population. However, each catheter placed 
into a central vein may induce some morbidity and complications .The complications 
are mainly mechanical, thrombotic and infections. Catheter-related bloodstream 
infection is perhaps the most important complication. Catheter-related bloodstream 
infection is the second most important cause of nosocomial infection in the intensive 
  
care unit (ICU) and considerably increases costs of hospitalization. Up to 90% of 
catheter-related bloodstream infections originate from CVCs. Bacteremia occurred in 
5% of patients with 48 hours. (M.Zurcher, Tramer and Walder 2004) 
             Patients with catheter-associated bloodstream infection had significantly longer 
in ICU and hospital lengths of stay, with higher unadjusted total mortality rate and 
hospital cost compared with uninfected patients.          (Warren et al., 2006) 
             Central venous catheters (CVCs) are increasingly used in the inpatient and 
outpatient setting to provide long-term venous access. The most common complications 
of CVCs are infection, suppurative, thrombophlebitis, and mechanical complications 
such as thrombosis. Infection of CVCs is a particularly common form of nosocomial 
infection. It is estimated, for example, that approximately 90 percent of the 50,000 to 
100,000 annual catheter-related bloodstream infections in the United States occur with 
Central Venous Catheters.          (Jeffrey D Band 2009). 
               Central venous cannulation has become a standard procedure since introduced 
to medical practice in the 1950s. 80 % of hospitalized patients receive a central venous 
catheter and more than five million central venous catheters are inserted in the United 
States each year.    (Alan C and Heffner, 2007) 
             Most of the studies have demonstrated a higher rate of colonization under 
transparent dressing than under gauze. The higher rate of colonization observed with 
transparent dressing has not been consistently associated with a higher infection rate. 
Colonization is an important determinant of CVC related infection. “Breathable” 
transparent dressings reduce the growth of microorganisms. Use of topical antimicrobial 
agents has not been consistently demonstrated to reduce the rate of infection.   
 (Jones 2007) 
  
              Lucet et al., (2010) stated that scheduled replacement of central venous 
catheters and by extension of arterial catheters is not recommended because the daily 
risk of catheter related infection is considered constant over time after the first catheter 
days. Arterial catheters are considered at lower risk of catheter related infection than 
central venous catheters. 
             Bobo and Dubberke (2010) stated that intensivisits should be aware that 
epidemiology,   risks and prevention measures may differ between the micro-organisms. 
In addition intensivisits should be ready to implement systems changes related to 
notification, isolation precautions and prevention and environmental cleaning in the 
intensive care unit. 
               Hospital acquired infections have profound social, economic and personal 
costs to patients in the intensive care unit (ICU). Numerous risk factors, such as poor 
nutrition and hyperglycemias, directly involve patients. Meanwhile, hand hygiene, 
environmental cleaning and appropriate hospital staffing can impact ICU infection rate    
(Barsanti 2009) 
            No studies have demonstrated any reduction in CVC infection rates with oral or 
parenteral antibacterial or antifungal drugs given during catheter insertion. In contrast 
numerous studies have reported that antibiotic administration in patients with a CVC in 
situ significantly reduced the risk of catheter colonization and blood stream infections.      
(Frasca , Dahyot –Fizelier and Mimoz 2010) 
            Compared with simple gauze dressings, transparent semi permeable dressings 
are more expensive but permit easy inspection of the site, stabilize the catheter, may 
offer an advantage to patients who are mobile, and have been left in place for up to 7 
days. (Brenda crispell 2003) 
  
            Tegaderm — Film has a ""frame"" and "first aid" delivery system that makes 
placement quick and easy. Breathable film provides a bacterial and viral barrier to 
outside contaminants. It offers two, unique, different transparent adhesive dressing 
systems, giving the clinician a choice for patients with sensitive skin or a need for 
increased holding power in the presence of moisture .(Jones –Walton 2010) 
             Several studies have found increased bacterial colonization in warm, moist, 
occluded sites under transparent semi permeable (both conventional and the newer, 
highly permeable) dressings. (Davison 2002) 
           There are increasing numbers of patients, both at home and in the hospital, 
receiving intravenous therapy via long-term central venous catheters. Although fairly 
commonplace, there are many potential complications associated with the insertion and 
use of these catheters. They have recommended the nurse to have more information and 
confidence required for observing, detecting, preventing and or treating promptly any 
complication to ensure the best possible nursing care.   (Sarah Drewett 2000) 
             Central venous catheters are integral to the care of acutely ill patients, providing 
reliable vascular access for infusions, hemodynamic monitoring, and blood sampling. 
However, there are risks associated with their use, the most common of which is central 
line-associated blood stream infections. These infections result in increased lengths of 
stay, increased costs, and high mortality rates. (Suzan, Miller-Hoover, Leigh Small  
2005) 
                           Central venous catheter is inserted with the tip resting in the distal end 
of the superior vena cava or the right atrium of the heart. Care requirements include cap 
change, cleansing, heparin flush and dressing change. (Lewis 2007) 
                     Agarwal (2001) reported that strict adherence to hand washing and aseptic 
technique remains the corner stone of prevention of catheter related infection. However, 
  
other measures may confer additional protection and must be considered when 
formulating preventive strategies .These measures include the selection of an 
appropriate site of catheter insertion and type of catheter material, use of barrier 
precautions during catheter insertion, use of transparent dressings, and replacement of 
catheters, administration sets and intravenous fluids at appropriate intervals. 
                Roberta Kaplow Sony R.Hardin (2009) reported that patients are at high risk 
for Hospital Acquired Infection; particularly when they are in the Intensive Care Unit.  
ICU infections with resistant pathogens increase both morbidity and mortality rates. 
Prevention strategies focus on the use of protective measures and early identification of 
Hospital Acquired Infections. To protect their patients, critical care nurses must be 
aware of all policies and procedure that reinforce aseptic patient care technique. 
Familiarity with high risk procedures and infection control prevention strategies.  
             
 
                             SIGNIFICANCE AND NEED FOR THE STUDY               
             “Any profession which doesn’t monitor itself becomes a technology” 
                                                                         -Marie Phancuf 
             Catheter-associated bloodstream infections remain an important cause of 
nosocomial infection, with an estimated 50,000–100,000 cases occurring each year in 
the United States. Central venous catheters are believed to be responsible for 90% of 
such infections. The cumulative risk of acquiring a catheter-related bloodstream 
infection has ranged between 1 to 10% for central venous catheters in general and 6% 
for total parenteral nutrition catheters. The skin is the most common source of 
organisms causing catheter-related infections. (Karim, Adal and Barry Farr 2008) 
  
                             The indication for the use of central line include monitoring of the 
central venous pressure(CVP) in acutely ill patients to quantify fluid balance, long term 
intravenous antibiotics, long term parenteral nutrition especially in chronically ill 
patients, long term pain medications, chemotherapy, drugs that are prone to cause 
phlebitis in peripheral veins, frequent blood draws.     (Ronark.I.Kuna 2008) 
               Central venous catheter line is needed for patients receiving chemotherapy 
over a long period of time, candidate for a blood or bone marrow transplantation. These 
catheters stay in place for long period of time and allow health care providers to give 
medications and blood products and take blood samples without having repeatedly 
poked the vein.    (Karen Raymaakers 2010) 
            Jeffery Band (2009) has explained that Central venous catheter line is to be cared 
under strict adherence to hand washing and aseptic technique to reduce central venous 
catheter related infection Aqueous chlorhexidine appears more pronounced effect as 
demonstrated in a trial which randomized 662 central venous catheter or arterial catheter 
insertion to disinfection of the site prior to insertion and to subsequent site care with 
10% povidine iodine, 70% alcohol, 2% chlorhexidine. Chlorhexidine was associated 
with a lower of both catheter related infection (2.3 vs. 9.3 and 7.1 per 100 catheters) and 
catheter related bacteraemia (0.5 vs. 2.3 and 2.6 per 100 catheters).      
             Catheter related infection rate is high in Intensive care unit. Approximately 48% 
of all Intensive care unit patients have central venous catheters at some point during 
their hospital stay. Central venous catheters disrupt the integrity of the skin, leading to a 
portal for pathogen entry and subsequent central venous catheter related blood stream 
infection. Approximately 90% of catheter related blood stream infections occur with 
central venous catheters. Mortality attribute to central venous catheter related blood 
  
stream infection is between 4% to 20%. An estimated 500 to 4,000 U.S patients die 
annually due to blood stream infection.   (Tom.R.Talbot, 2007) 
             Safdar and Klunger (2002) conducted prospective study in Madison on 
strategies for preventing central venous catheter related blood stream infections. Risk 
factors was associated with inexperience of the operator and nurse to patient ratio in the 
Intensive Care Unit, catheter insertion with less than maximal sterile barriers, placement 
of central venous catheter in the internal jugular or femoral vein rather than subclavian 
vein, contamination of the catheter and duration of  central venous catheter placement > 
7 days. 
             Krein et al., (2007) conducted a survey in non federal hospitals in US. Findings 
revealed that most US hospitals are using maximal sterile barrier precaution and 
chlorhexidine gluconate, and it was the most strongly recommended practices to prevent 
Catheter Related –Blood Stream Infections (CR-BSIs). 
            Catheter care protocols programs that help health care providers to monitor and 
evaluate care are crucial for the success of preventive measures. Educational programs 
with hygiene training and protocols concerning the preparation of the equipment, skin 
antiseptics, detailed insertion techniques, catheter manipulation (e.g.) Hand hygiene and 
catheter care are effective when staff members are involved in designing the measures 
included in the program. Educating and training of health care providers who insert and 
maintain central venous catheters is essential for preventing catheter related infection, 
improving patient outcomes, and reducing health care costs.   (Farah erach 2005). 
             The use of central venous catheters (CVCs) for vascular access is now common 
place in a variety of care settings. Technological advances related to CVCs have 
introduced a multitude of catheter designs that are available to us through numerous 
manufacturers. To initiate the appropriate procedures for care, nurses involved in the 
  
maintenance of central venous access devices. And they are now challenged with having   
familiar with a large variety of central venous access devices. It must be able to evaluate 
a CVC and determine its type, size, manufacturer, and specific characteristics as well as 
to initiate the appropriate management strategies related to that device. They must also 
be able to recognize the indications, advantages and disadvantages associated with each 
device, and to assist the patient in making an informed decision regarding the 
appropriate device for his or her therapy needs. It is essential that care and maintenance 
procedures should be delivered by those who have knowledge base and experience 
make them competent care providers with the expertise to initiate appropriate prevention 
and troubleshooting measures, as well as to evaluate and implement nursing actions 
related to complication (Baranowski 2004) 
            Infections can be decreased with strict sterile technique when changing 
dressings, and monitoring the patient closely for any signs of infection, including fever, 
redness or soreness at the site of insertion, and drainage from the insertion site. (Lewis 
2007) 
             Catheter-related bloodstream infection remains the most serious complication of 
central venous access and a leading cause of nosocomial infection in the ICU. 
Prevention of catheter-related infection involves several measures which should be used 
in combination. The most important include the use of a checklist to guide catheter 
insertion and maintenance; adequate training of the nursing staff involved in the 
management of vascular access and an adequate patient-to-nurse ratio; the use of 
maximal sterile barrier precautions during catheter insertion; preference for a 
chlorhexidine-based solution for skin antisepsis and use of the subclavian vein whenever 
possible; cleaning hands with an alcohol-based hand rub solution before any 
manipulation of the infusion line; and removing any useless catheter. As with any 
  
device used in the ICU, healthcare workers caring for a patient with a central venous 
access device need to be adequately trained, and assessed as being competent in using 
CVCs and adhering to infection prevention practice. (Julie Santy 2006) 
              The density of microorganisms at the catheter insertion site is a major risk 
factor for catheter-related infection. And skin antisepsis is one of the most important 
preventive measures. Povidone iodine and chlorhexidine are the most commonly used 
antiseptic agents; Both are available as aqueous and alcoholic solutions. Their respective 
efficacy in preventing catheter colonization and bloodstream infections has been 
compared in numerous studies. (Frasca, Dahyot –Fizelier and Mimoz 2010) 
           In a meta-analysis, the use of a chlorhexidine-impregnated sponge placed over 
the site of short-term vascular and epidural catheters significantly reduced the risk of 
catheter colonization but not catheter-related bloodstream infection compared to 
standard dressing. (Frasca, Dahyot –Fizelier and Mimoz 2010) 
                      Preventing central venous catheter infection in Intensive care unit is an 
important priority for nurses. Being nursing personnel, it is a need to find out the more 
effective protocol to reduce the number of central venous catheter infection cases. This 
motivated the researcher to do study on this topic .This study is undertaken to high 
lighten the effective dressing in prevention of central venous catheter infection. 
 
                                       STATEMENT OF THE PROBLEM: 
 A study to assess the effectiveness of chlorhexidine 2% with transparent 
polyurethane (tegaderm)  dressing on preventing infection and cost effectiveness among 
patient with central venous catheter in selected  Hospital at Madurai. 
 
 
  
OBJECTIVES: 
1. To find out the level of infection among patients with CVC after application of 
chlorhexidine 2% with transparent polyurethane (Tegaderm) and routine 
dressing on 3rd and 6th day. 
2. To evaluate the effectiveness of 2% chlorhexidine with transparent polyurethane 
(Tegaderm) application in preventing infection among patient with CVC in the 
experimental group on 3rd and 6th day. 
3. To evaluate the effectiveness of routine dressing in preventing infection among 
patients with CVC in the control group on 3rd and 6th day. 
4. To compare the post infection rate among CVC patient on experimental group 
with control group in 3rd and 6th day. 
5. To compare the cost effectiveness of transparent polyurethane dressing 
(Tegaderm) with routine dressing among patient with CVC. 
HYPOTHESES: 
 All the hypotheses were tested at 0.05 level of significance. 
H1: There will be significant difference between the CVC site infection score on the 3rd        
and 6th day of the experimental group. 
H2: There will be significant difference between the CVC site infection score on 3rd and 
6th day of the control group. 
H3: The mean post infection score of patient with CVC who had of transport 
polyurethane (Tegaderm) dressing will be significantly lower than the mean infection  
score of patient with CVC who had routine dressing on 3rd & 6th day. 
H4: There will be significant difference in terms of cost who has received Tegaderm 
with  routine treatment over the CVC site. 
 
  
OPERATIONAL DEFINITIONS: 
Effectiveness: 
            It means that in a way which produces the intended result (or) a successful result. 
 In this study, it refers to the outcome for transparent polyurethane (tegaderm) 
dressing  and Betadine gauze dressing in preventing infection among the patient with 
central venous catheter which was assessed through  MR VICTOR Tool (Multi Racial 
visual Inspection catheter tool observation Record) and if there is any excessive 
discharge at central venous catheter site culture results was taken. MR VICTOR tool of 
central venous catheter site is attached in Appendices IV in page number- 73. 
Chlorhexidine 2%: 
 It is a powerful, non-irritating antiseptic that disrupts bacterial cell membrane. In 
this study 2% chlorhexidine was used to clean the central venous catheter site once in a 
day. 
 
Transparent Polyurethane dressing (Tegaderm): 
 Transparent polyurethane dressing was used to protect the catheter site from 
external contamination, to secure the central venous catheter and to discourage bacterial 
proliferation near the insertion site.  In present study it refers to the dressing used at the 
CVC line, which will be changed every 24 hours for 7 days. In this study, subjects who 
received transparent polyurethane (tegaderm) dressing at central venous catheter site 
were included in the experimental group. 
Betadine Gauze Dressing: 
 It is a microbial agent, which helps in preventing infection. It refers to cleaning 
the central venous Catheter with 5% of betadine solution followed by an application of 
gauze soaked in betadine solution over the Central venous catheter site.  Dressing was 
  
applied to the Central Venous Catheter site once in a day.  In this study subjects who 
received betadine gauze dressing at central venous catheter site were included in routine 
treatment (control group). 
 
 
Infection: 
           It is the invasion of the body by microorganisms that reproduce and multiply 
causing disease. 
 It refers to the entering of micro-organism to the central venous catheter site 
which was   assessed by the use of MR VICTOR Tool and culture results. 
Cost Effectiveness: 
 It is defined as producing useful results in relation to its cost. 
 It refers to the comparison between of the amount spend for transparent 
polyurethane (Tegaderm) dressing with betadine gauze dressing  change at the central 
venous catheter site. 
Central Venous catheter: 
 It is a catheter placed into a large vein in the neck (or) thigh.  It is used to 
administer medication or fluids obtain blood tests and directly obtain cardiovascular 
measurements. 
            In this study, patients who had central venous catheter used to administer 
medication and fluids were selected. 
ASSUMPTIONS: 
1. Central venous catheter infection rate can be detected by frequent observation. 
2. Nurses have got an important role in providing central venous catheter care. 
3. Nurses have got responsibility in providing cost effective care to the patients. 
  
DELIMITATION: 
The study is delimited to 
a. Both adult male and female patients with central venous catheter at    
Jugular vein and subclavian vein 
      b. Patients who are admitted in the selected hospital during the period of  
            Data collection 
c. The data collection period is limited to 6 weeks. 
d. Patients who had transparent polyurethane dressing or betadine gauze 
dressing over the central venous catheter site for 7 days. 
PROJECTED OUTCOMES: 
              The study will be useful for the nurses to enlighten their knowledge regarding 
central venous catheter care and observation. By that it helps prevention of central 
venous catheter site infection among patients who are in central venous catheter. 
CONCEPTUAL FRAME WORK: 
 
             The study was based upon J.W.Kenny’s open system model. All living systems 
are open in that there is a continual exchange of matter, energy and information .Open 
systems have varying degrees of interaction with the environment from which the 
system receives input and gives back output in form of matter, energy information. For 
survival, all systems must receive varying types and amount of matter, energy and 
information. 
             The main concepts of the system model are Input, Throughput and Output and 
Feedback. 
INPUT: 
       In this open system theory, Input refers to the matter, energy and information that 
enters into the system through its boundary. In this study it refers to application of 2% 
  
chlorhexidine with transparent polyurethane (tegaderm) for experimental group and 
routine betadine gauze dressing for control group. 
 
THROUGHPUT: 
         In this open system theory, throughput refers to processing where the system 
transforms the matter, energy and information. In this study it refers to protect the 
central venous catheter from external contamination in experimental group and in 
control group by microbial agent which helps in preventing infection at central venous 
catheter site. 
OUTPUT: 
         In this open system theory, output refers to the matter, energy and information that 
are processed. After processing the input, the system returns output (matter, energy and 
information) to environmental in an altered state .In this study it refers to the  samples in 
experimental group was treated  2% chlorhexidine with transparent polyurethane 
(tegaderm) reduce the catheter related infection and routine betadine gauze dressing has 
only mild effect on  prevention of catheter related infection . 
FEEDBACK: 
         In this open system theory, feedback refers to environmental response to the 
system’s output used by the system adjustment, correction and accommodation to the 
interaction with environment. In this study it refers on the analysis of post test infection 
assessment of central venous catheter site on care of patients. If severe infection occurs 
culture can be taken and the same pattern can be followed once again. 
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Figure 1: CONCEPTUAL FRAME WORK BASED ON 
     J.W. Kenny’s Open System Model                                                     
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CHAPTER II 
                                       
                                        REVIEW OF LITERATURE 
 
                          The primary purpose of reviewing relevant literature is to give a broad 
background knowledge (or) understanding of the information that is available related to 
the research problem of interest .( Burns-2001) 
       This chapter consists of,  
       1.   Literature related to common types and uses of central venous catheter 
      2.    Literature related to central venous catheter infection 
      3.   Literature related to role of chlorhexidine in reducing infection at central  
            Venous catheter site                   
      4.   Literature related to role of betadine in reducing infection at central venous 
           Catheter site                        
      5.   Literature related to cost effectiveness 
Literature related to common types and uses of central venous catheter 
                Paul L.Marino (2006) stated that the types of central venous catheter are 
single, double and triple lumen, peripherally inserted central catheter, implanted central 
line, percutaneously inserted central venous catheters. 
                Jeffrey D Band (2010) explained percutaneously inserted central venous 
catheters are the most commonly used central catheters .Most central venous catheters 
are inserted centrally into the subclavian, jugular and femoral veins. However, 
peripherally inserted central catheters (PICCs) continue to gain in popularity because of 
the following advantages: The relative ease of insertion into the cephalic or basilar vein 
of the anticubital fossa; a low risk of complications good patient tolerance. 
  
            (Frasca, Dahyot, Fizelier and Mimoz 2010) conducted a Comparative study to 
assess the mono-lumen catheters and the use of multiple lumen catheters on catheter 
colonization and Blood Stream Infection. The findings revealed that when compared to 
mono-lumen catheters, the use of multi -lumen catheters was associated with 
comparable risks of catheter colonization (RR: 0.80 [95% CI: 0.43-1.50]), but higher 
risks of bloodstream infection (RR: 2.26 [95% CI: 1.06-4.83]). The increased risk of 
bloodstream infection is explained by one study which included long-term catheters 
(mean duration of catheterization longer than 20 days) for parenteral nutrition and 
reported a surprisingly high level of infection with multiple lumen catheters (13.1%) 
versus (2.6%) with mono-lumen catheters). 
 
   Literature related to central venous catheter infection 
            Frasca and  Dahyot-Fizelier  (2010) conducted five  randomized studies among 
617 Intensive Care Unit (ICU) patients at France .This study is based on the prevention 
of central venous catheter related infection in the Intensive Care Unit (ICU), evaluated 
the performance of a catheter coated on its extra luminal site with chlorhexidine  were 
included in a meta-analysis. Compared to a standard catheter, the use of the coated 
catheter decreased the risk of catheter colonization (relative risk, RR: 0.59 [95% CI: 
0.50-0.71]) and bloodstream infection (RR: 0.66 [95% CI: 0.47-0.93]). There is no 
evidence for multi-resistant bacteria on selection with antibiotic-coated catheters. The 
use of CVCs coated with antimicrobial agents should be reserved for ICUs where, the 
incidence of catheter-related infection is more. 
              Allan D (2008) Conducted a meta-analysis of three prospective non-
randomized studies compared catheters inserted in the internal jugular (n = 278) and 
subclavian (n = 429) veins. The use of the internal jugular vein was associated with a 
  
non-significant increase in the risk of bloodstream infection (RR: 2.24 [95% CI: 0.2-
22.1]) compared to the subclavian route. Moreover, multivariate analysis of several 
prospective studies has shown more frequent infectious complications when using 
femoral or internal jugular access. 
             Pearson (2002) done a randomized multicenter study evaluated the risk of 
complications with dialysis catheters in the ICU according to femoral or internal jugular 
insertion site. A total of 750 catheters with an average duration of insertion of 6 days 
were included. The risk for colonization was comparable for both sites (incidence of 
40.8 vs. 35.7 per 1000 catheter-days for the femoral and jugular sites, respectively, RR: 
0.85 [95% CI: 0.62-1.16]). Nevertheless, the risk of colonization with internal jugular 
access was increased in patients with a body mass index less than 24.2 (RR: 2.10 [95% 
CI: 0.23-0.69]) and decreased in patients with a body mass index greater than 28.4 (RR: 
0.40 [95% CI: 1.13-3.91])      
            Victor Daniel Rosenthal et al., (2003) conducted a prospective study about 
nosocomial infection in medical surgical intensive care unit in Argentina about 2 months 
surveillance. The most common site of infection was catheter related blood stream 
infection 32% .The rate of central venous associated with blood stream infection in 
medical surgical intensive care unit was 44.6 per 1000 days with an attributable  
mortality of 25% and excess hospital stay. 
Literature related to role of chlorhexidine in reducing infection at central 
venous catheter site 
                        Heiner Ruschulte et al., (2008) conducted a randomized, prospective, 
open, controlled clinical study among 601 patients in university hospital about 
Prevention of central venous catheter related infections with chlorhexidine gluconate 
impregnated wound dressings for cancer patients received chemotherapy. Daily routine 
  
included clinical assessment of the insertion site (swelling, pain and redness), 
temperature, white blood count and C-reactive protein had been done. The incidence of 
CVC-related infections were 11.3% (34 of 301) and 6.3% (19 of 300) in the control and 
Chlorhexidine-impregnated wound dressing groups, respectively (p=0.016, relative risk 
0.54; confidence interval 0.31–0.94). Especially, catheter-related infections at internal 
jugular vein insertions could be reduced (p=0.018). The use of chlorhexidine-
impregnated wound dressings significantly reduced the incidence of CVC-related 
infections in patients receiving chemotherapy. 
                  David and Veenstra (2007) did a randomized trials comparing 
chlorhexidine–silver sulfadiazine–impregnated central venous catheters with no 
impregnated catheters were included. Twelve studies met the inclusion criteria for 
catheter colonization and included a total of 2611 catheters. Most patients in these 
studies were from groups considered to be at high risk for catheter-related infections 
The ratio for catheter colonization was 0.44 (95% confidence interval [CI], 0.36-0.54; 
P<.001), indicating a significant decrease in catheter colonization associated with 
impregnated catheters. This study concluded that central venous catheters impregnated 
with a combination of chlorhexidine and silver sulfadiazine appear to be effective in 
reducing the incidence of both catheter colonization and catheter-related bloodstream 
infection in patients at high risk for catheter-related infections.  
                         Gilles and Riordan L (2002) have done a randomized controlled trials 
evaluating the effects of dressing type (i.e. gauze and tape and/or transparent 
polyurethane dressings) on central venous catheter sites in Australia. Of the 23 studies 
reviewed, 14 were excluded. Nine studies were included. Data was only available for 
meta-analysis from six of the nine included studies .The conclusion of the study was 
there was a high level of uncertainty regarding the risk of infection with the central 
  
venous catheter dressings identified in this review. Therefore, at this stage it appears that 
the choice of dressing for central venous catheters can be based on patient preference to 
identify the most appropriate central venous catheter dressings. 
                     Lawson and Millie (2006) undertook a comparative study on transparent 
dressing to paper tape dressing over central venous catheter sites which were evaluated 
in 365 cancer patients with newly inserted central venous catheters and were they 
randomly assigned to one of two treatment groups. (1) Transparent dressing (tegaderm) 
changed twice in week n=188. (2) Paper tape dressings changed three times a week 
n=177.Patients is observed for signs of infection, phlebitis and dressing adherence. 
Transparent polyurethane dressings worn up to 7 days were equivalent to paper tape 
dressing worn for shorter periods with respect to incidence of phlebitis and infection, 
however maintenance cost can be reduced. 
                       Madeo et al., (1998) conducted a randomized trial comparing Arglaes 
(transparent dressing containing silver ions) to tegaderm (a transparent polyurethane 
dressing) for dressing peripheral arterial catheters and central vascular catheters among 
31 patients in UK admitted in ICU. Skin swabs were taken from the insertion site prior 
to catheterization and on removal of the intravascular device to measure skin 
colonization rates between the two dressings. The catheter tips were also cultured on 
removal to establish if there was a difference between the two groups .No statistical 
differences were found in bacterial growth between the two dressings. 
                             Gilles D et al., (2009) conducted a study on gauze and transparent 
polyurethane and tape dressing for central venous catheters. Several different kinds of 
dressing were used for protecting the central venous catheter site. These may vary in 
their durability, ease of use, ability to prevent infection and skin reaction. However, the 
  
review of trials found there was not enough evidence to determine any of the dressings 
for central venous catheters and they are better than any of the others. 
                                 
 Literature related to role of betadine in reducing infection at central venous 
catheter site 
               Frasca , Dahyot –Fizelier and Mimoz (2010) had done a Meta analysis study 
among 4143 short term catheters (1568 central venous catheters, 1361 peripheral venous 
catheters, 704 arterial catheters and 395 pulmonary artery catheters) in hospitalized 
patient. To compare chlorhexidine to a aqueous povidone iodine .The use of 
chlorhexidine catheters than povidone iodine aqueous solution significantly reduced 
catheter related blood infections by approximately 50 % [RR: 0.51 (95% CI, O.27 -
0.97)]. For every 1000 catheter sites disinfected with chlorhexidine solutions rather than 
povidone iodine solutions, 71 episodes of central venous catheter colonization and 11 
episodes of infection would be prevented.  
                Chiayakunapruk ,Veenstra , Lipsky and Saint (2002) conducted a randomized 
clinical trials with outcomes defined that the relative risk of colonization and catheter 
related blood stream infection were significantly lower than with chlorhexidine 
compared to povidone iodine. 
Literature related to cost effectiveness 
                 David , Sanjay and  Sullivan,(2005) conducted a case analysis, use of an 
antiseptic-impregnated catheter compared with a standard catheter resulted in an 
expected saving of costs of $196 per catheter .The expected incidence of CR-BSI 
decreased from 5.2% for standard catheters to 3.0% for antiseptic-impregnated 
catheters, an absolute decrease of 2.2% and relative decrease of 42%. The expected 
incidence of death attributable to the combination of CR-BSI and/or hypersensitivity 
  
reaction decreased from 0.78% to 0.45%, an absolute decrease of 0.33% and a relative 
decrease of 42%. The incidence of local infections decreased from 12.4% to7.5%. The 
calculation of an incremental cost-effectiveness ratio (e.g., cost per death avoided) was 
not conducted because the intervention is dominant greater efficacy and lower costs. 
          J C Shivnan et al., (2009) done a randomized, prospective study to compare two 
types of catheter dressings in 98 patients undergoing Bone marrow transplantation 
(BMT): a dry sterile gauze dressing (DSGD) changed daily and a transparent adherent 
dressing (TAD changed every four days in Johns Hopkins Oncology Centre. Study 
outcomes included incidence and severity of local and systemic complications, patient 
assessment of comfort, and calculation of nursing time. One case of catheter-related 
infection occurred during the study. No significant differences existed between the two 
dressings in the incidence of positive skin cultures or local complications with the 
exception of skin irritation. The TAD which caused less skin irritation, was preferred by 
patients, cost less, and required less nursing time. The findings indicate that TADs 
provide a safe, comfortable, and cost-effectiveness for patients undergoing BMT and 
receiving antibiotic support during aplasia.     
 
 
 
 
 
 
 
 
  
                                                CHAPTER III 
RESEARCH   METHODOLOGY 
                     The research methodology indicates the general pattern of organizing the  
Procedure of gathering valid and reliable data for an investigation. This chapter provides  
a brief description of the method adopted by the investigator in this study. 
            It includes the research approach, research design, the setting, the population, the 
sample and criteria for the sample selection. It further deals with the development of 
tool, pilot study and procedure for data collection and plan for data analysis 
Research Approach: 
               An experimental approach was used for this study. This study was designed to  
assess the effectiveness of transparent polyurethane (tegaderm) and betadine dressing on  
preventing infection and cost effectiveness among patients with central venous catheter. 
Research Design: 
      The quasi experimental post-test only design with experimental and control group 
was chosen for the study. Post –test only design is the design in which data on 
dependant variable are collected only once after the experimental treatment has been 
introduced (Polit, 2007) 
The research design used in the study is diagrammatically represented below. 
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Key: 
T1 – Application of transparent polyurethane (tegaderm) dressing among patients       
with  CVC  in experimental group. 
T2– Application of routine betadine gauze dressing among patients with CVC in control 
group. 
O3   O6   – Post assessment of the CVC site on 3
rd and 6th day in both the groups. 
Independent variable – Transparent polyurethane (tegaderm) and Betadine dressing. 
Dependent variable - Infection at central venous catheter site. 
SETTING OF THE STUDY 
                   This study was conducted in the Apollo hospital and Shenbagum hospital 
Madurai. 
          Apollo hospital is ½ km away from Sacred Heart Nursing College. The hospital is 
a multi specialty hospital having 250 beds. There are 6o beds in Intensive Care Unit 
(ICU), Cardiac Care Unit (CCU) and nearly 20 patients are with central venous catheter 
per day.  
              Shenbagum hospital is 1 km away from the Sacred Heart Nursing College. The 
Hospital has a multi specialty facility with 125 beds.  There are 10 beds in Intensive 
Care Unit (ICU) setting and nearly 4 -5 patients are admitted with central venous 
catheter per day.      
STUDY POPULATION: 
              The populations of the study were patients with Central Venous Catheter 
admitted in Intensive Care Unit (ICU) of Apollo and Shenbagum hospital 
 
 
  
SAMPLE: 
         Patient with central venous catheter both male and females who fits inclusion 
criteria were selected. 
SAMPLE SIZE: 
         The sample size was 60 patients, out of which 30 patients were in the 
experimental group and 30 patients were in the control group. 
SAMPLING TECHNIQUE: 
            Purposive sampling technique was used to select the sample .It’s a type of non –
probability sampling method in  which the researcher selects participants for the study 
on the basis of personal judgment about which ones will be most representative also 
referred to as judgmental sampling (Polit 2007). 
CRITERIA FOR SAMPLE SELECTION: 
         The sample was done based on the following inclusion and exclusion criteria. 
INCLUSION CRITERIA: 
1.   Central Venous Catheter usage to administer I.V. fluids, medications, blood  
                products and hemodynamic monitoring was included from Apollo and  
              shenbagam hospital. 
        2.    Patients with central venous catheter in site for 7 days. 
         3    Both male and female patients. 
         4.    Patients with jugular and subclavian central venous catheter site. 
EXCLUSION CRITERIA: 
1. Patients with arterial, pulmonary catheters and femoral central venous catheter 
site. 
2. Patients who have already developed infection at the site of CVC line. 
  
3. Central venous catheter with administration of dialysis and total parenteral 
nutrition. 
RESEARCH TOOL AND TECHNIQUE: 
Tool - I: 
          This consists of demographic variables such as age, gender, marital status, site 
and types of Central Venous Catheter. 
 
Tool - II: 
                This consists of MR VICTOR Tool (Multi Racial Visual Inspection Catheter 
Tool Observation Record) to assess the infection rate on central venous catheter line 
.Total questions were 5.The maximum score of questions were 10. The score ranges 
from 0 to 4.The tool describes about the scoring and signs and symptoms. 
           Score “o” indicates – No infection 
            Score 1 and 2 indicates – Mild infection 
            Score 3 indicates – moderate infection. 
            Score 4 indicates – severe infection. 
No Infection: 
          No fever, No discharge, Dry & Clean wound. 
Mild Infection: 
          Mild  fever, Mild serum discharge. 
Moderate Infection: 
           Fever, pus wound, serum discharge,  
Severe Infection 
         Catheter blockage, catheter tip culture positive 
  
          MR VICTOR is a universal tool that is transferable to all clinical areas and 
suitable for primary and acute care. The tool is used to recognize early signs of 
infection, prevent complication and speed up the removal of central venous catheters. It 
is a unique visual tool for health care professionals, which had both pictures and a 
scoring system to assess the levels of infection for different skin colors.  (Bethel 2005) 
             This scale is down loaded from internet and used as it is without doing any 
modification. 
 
VALIDITY:  
                                 Testing of the tool 
            MR VICTOR Tool (Multi Racial Visual Inspection Catheter Tool Observation 
Record) was established by Dee Waterhouse and Jean Winter bottom (http:// 
www.ncbi.nlm.nih.gov/pubmed citated in the internet on Feb. 2010). In present study 
investigator checked the validity of the tool by submitting the tool to five experts in the 
field of medical and two experts in the field of nursing. Based on their suggestion tool 
was accepted as it is. No modification was done. 
RELIABILITY: 
     Inter-rator reliability was used to establish the reliability of the tool. karl Pearson’s 
co-efficient of co-relation was used (r =0.8). 
DEVELOPMENT OF INTERVENTION 
Definition: 
              In this study two types of dressing are used i.e. 2% chlorhexidine with 
transparent polyurethane (tegaderm) dressing and routine betadine gauze dressing.The 
transparent polyurethane dressing was used to protect the catheter site from external 
  
contamination, to secure the central venous catheter and to discourage bacterial 
proliferation near the insertion site. It is a microbial agent, which helps in preventing 
infection. It refers to cleaning the central venous Catheter with 5% of betadine solution 
followed by an application of gauze soaked in betadine solution over the Central venous 
catheter site 
Aim: 
         To prevent infection on central venous catheter site infection. 
Steps in procedure: 
 Establish and maintain a trust worthy relationship. 
 Self introduction about the importance of dressing changes on central venous 
catheter site. 
 Wear mask and wash hands thoroughly for 15 sec. 
 Put on clean gloves and remove the old dressing on the CVC site. 
 Inspect the area around the site for any signs of infection by using MR 
VICTOR TOOL. 
 Open the sterile dressing tray 
 Clean the area with 2% chlorhexidine for experimental group and use 
betadine solution for control group 30 seconds and allow dry for 30 sec. 
 Apply transparent polyurethane (tegaderm) in experimental group and soaked 
betadine gauze in control group. 
 Remove the gloves and discard it. 
 Secure the dressing with adhesive tape in control group. 
 Assessment done on 3rd and 6th day in experimental and control group by 
using MR VICTOR Tool. 
  
PILOT STUDY: 
      In order to test the feasibility, relevance and practicability of the study was 
conducted among six patients with central venous catheter (among that 3 patients for 
experimental group , 3 patients for control group ) in the same manner as that of the 
original study in private hospital at Madurai .Data were analyzed to find out the 
suitability of statistical method. It revealed that the study was feasible. 
DATA COLLECTION PROCEDURES: 
          Before starting the study, the researcher obtained formal permission to conduct 
the study from the Apollo and Shenbagum hospital authority and the dissertation 
committee of Sacred Heart Nursing College .The period of study extended for 6 weeks.  
The researcher explained the objectives of the study to the physicians, surgeons and 
other nursing staff, patients before starting the data collection so, as to get co-operation 
in the procedure of data collection.  The subjects were divided into experimental and 
control group. Initially the subjects were interviewed in order to collect demographic 
data. 
              In experimental group, the central venous catheter site was cleaned with 2% 
Chlorhexidine solution followed by transparent polyurethane (tegaderm) application 
once in a day continuously for seven days, on the 3rd and 6th day the post assessment of 
the infection rate was assessed by MR VICTOR Tool. 
             In control group , the central venous Catheter site was cleaned with 5% 
Betadine solution followed by betadine soaked gauze dressing application was done 
once  a day continuously for 7 days.  On the 3rd and 6th day the post assessment of 
infection rate was assessed by MR VICTOR Tool. For each sample approximately 30 
minutes was spent. The investigator does not experienced problem in the data collection 
process. 
  
DATA ANALYSIS: 
                       After the data collection, data was tabulated, summarized and analyzed.  
The data was analyzed as follows: 
Computation of frequencies, percentage for demographic data. 
1. Paired ‘t’ test of significance was used to find out the effectiveness of 
dressing used for experimental and control group. 
2. Independent‘t’ test of significance was to find out the post mean infection 
assessment score of dressing used for experimental and control group. 
PROTECTION OF HUMAN RIGHTS: 
The pilot study and the main study were conducted after the approval of the ethical 
committee of the Sacred Heart Nursing College. Permission was obtained from the chief 
surgeon and physician of the Shenbagum hospital and Apollo hospital, Madurai. 
Assurance was given to the subjects, that confidentiality would be maintained. Oral 
consent was obtained from the study subjects .The subjects were explained about any 
time they have got the rights to withdraw from the study. There was an absence of 
Physical and psychological strain to study subjects during the data collection procedure. 
                                                        
 
 
 
 
 
 
 
 
  
                                                     CHAPTER IV 
                            DATA ANALYSIS AND INTERPRETATION 
                                This chapter deals with the description of the sample analysis and 
interpretation of data to assess the effectiveness of 2 % chlorhexidine with transparent 
polyurethane (tegaderm) dressing on preventing infection and cost effectiveness among 
patient with central venous catheter .The obtained data was classified , grouped and 
analysed statistically based on the objectives of the study. 
                            ORGANIZATION OF THE FINDINGS  
SECTION I:   Deals with frequency and percentage distribution of demographic     
                       characteristics of the samples 
SECTIONII: Deals with frequency and percentage distribution of central venous                                                                                             
.                        catheter site infection among the experimental and control group.   
SECTION III:   Comparison of central venous catheter site infection  
                       Score of subjects. 
               a. Comparison of mean central venous catheter site infection                           
.                      Assessment score of the experimental group on 3rd and 6th day  
                          b. Comparison of mean central venous catheter site infection    
                              score of the control group on 3rd and 6th day.   
                         c.   Comparison of mean central venous catheter infection score of  
  Experimental and control group on 3rd day.                                          
                         d.   Comparison of mean central venous catheter infection score of  
  Experimental and control group on 6th day.  
                         e.   Comparison of mean central venous catheter infection score of  
                              Experimental and control group 
  
 
Section IV:    Comparison of cost effectiveness of transparent polyurethane   
                          Dressing (tegaderm) and routine dressing among patient with 
                           Central venous catheter 
                             
 
 
 
                                                          
 
 
 
 
 
 
                                                 
 
 
 
 
 
 
 
   
 
  
 
SECTION -I 
                        DEMOGRAPHIC PROFILE OF THE SAMPLE   
Table 1 
            Distribution of sample according to demographic variables 
                                                                                              N=60 
 
Characteristics                Experimental                    Control                Total 
                                       Group (n=30)                      Group (n=30) 
                                          f            %                         f         %                 f        % 
Age (in years)                    
     20 – 40                         8          26.6                       3            10             11      18.33 
     41 – 60                       14          46.6                     17            56.6          31       51.66 
     61 – 80                        8           26.6                     10           33.3            18         30 
Sex  
    Male                            19          63.3                      20          66.6            39          65 
    Female                        11           36.6                     10          33.3             21          35 
Marital status 
   Married                        25           83.3                     26           86.6            51          85 
   Unmarried                    5             16.6                      4            13.3             9           15 
 
 
 
 
  
 
 
Characteristics                Experimental                        Control                Total 
                                       Group (n=30)                      Group (n=30) 
                                          f            %                         f         %                 f        % 
Site of CVC line                  
  Internal jugular vein     27             90                      29            96.6             56         93.33 
  Subclavian vein             3               10                       1              3.3               4          6.66 
Types of CVC  
   Double lumen               4               13.3                    3              10                7         11.66         
    Triple lumen                26              86.6                  27             90              53        88.33 
 
           The data presented in table 1 shows that majority of clients 14 (46.6%) in the 
experimental group belongs to the age group of 41 – 60 years and where as 17 (56.6%). 
In the control group belong to the age group of 41– 60 years. 
          With regard to sex, in the experimental group 19 (63.3%) were males and in the 
control group 20(66.6%) were males. 
           Regarding marital status in the experimental group 25 (83.3%) were married and 
in the control group 26 (86.6%) were married  
           With regard to site of the central venous catheter line, majority of the subjects in 
the experimental group 27 (90%) and control group 29 (96.6%) had central venous 
catheter at internal jugular vein. 
          With regard to the type of central venous catheter, 26 (86.6%) of clients had triple 
lumen catheter in the experimental group and 27 (90%) had triple lumen catheter in 
control group. 
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Figure 2:Distribution of Sample In terms of Site of Central Venous Catheter 
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                                                 TYPES 
Figure 3: Distribution of Sample In terms of Types of Central Venous 
Catheter. 
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SECTION –II 
TABLE 2 
                Deals with frequency and percentage distribution of central venous  
Catheter site infection among the experimental and control group                                             
              
                                                                                                         N = 60                                                                 
Level of infection                          experimental group             control group 
                                                               n= 30                                 n=30 
                                                   3
rd
 day         6
th
 day                   3
rd
 day      6
th
 day 
                                                  f        %        f        %               f      %        f        % 
No infection                             21     70        11     36.6            13    43.3      5       16.6 
Mild infection                           8      26.6      16     53.3           11     36.6     15       50 
Moderate infection                    1      3.3         3       10              6      20        10      33.3 
Severe infection                        -         -           -         -                -       -           -          - 
 
            Based on the level of infection obtained in the MR VICTOR tool. The subjects  
were classified into four groups, no infection (0), mild infection (1and 2), moderate  
infection (3), severe infection (4). A higher score indicates poor infection status where 
as  
a low score indicates good reduction in infection rate. 
          Table 2 shows that in experimental group majority of the subjects 21(70%) had  
no infection on 3rd day where as in control group only 13 (43.3%) had no infection. with  
regard to on 6th day assessment, in experimental group 11 (36.6%) had no infection. 
  
              Related to mild infection rate at central venous catheter, in experimental group  
8(26.6%) had mild infection on 3rd day and 11 (36.6%) had mild infection in control  
group. whereas after application interventions on 6th day 16 (53.3%) had mild infection  
in experimental group and 15 (50%) had mild infection in control group. 
             Moderate infection rate was found to be 1(3.3%) in experimental group on 3rd  
day, whereas control group had 6(20%). on the 6th day assessment should only least 3  
(10%) had moderate infection in experimental group, where as 10 (33.3%) had 
 moderate infection in control group. None of the subjects in both the groups had severe  
infection. This difference in experimental and control group may be due to the effect to  
transparent polyurethane (tegaderm) dressing.   
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Figure 4:   Distribution of central venous catheter site infection among the experimental and control group 
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SECTION - III 
Table -3 
             Comparison of mean central venous catheter infection  
score of the experimental group on the 3
rd
 and 6
th
 day 
                                                                                                      N = 30 
  
Level of infection                   N            Mean          SD       ‘t value’ 
        3rd day                             30            0.4              .70        
2.83 * 
        6th day                             30            0.9               .90 
  
*Significant at 0.05 level 
               In order to find out the difference of central venous catheter site infection  
assessment score between on the 3rd and 6th day of the experimental group, the null  
hypothesis was stated as follows: 
             Ho1 There will be no significant difference between the central venous catheter  
site infection assessment score on 3rd and 6th day of the experimental group. 
            Table 3 shows that the mean central venous catheter site infection assessment  
score on the 3rd day (o.4) is lower than the central venous catheter site infection  
assessment score on the 6th day (0.9) .The obtained ‘t’ value of 2.83 at degree of  
freedom 29  was significant at 0.05 level. This indicates that the difference between the  
mean 0.5 was  the true difference and has not occurred by chance. So the researcher  
rejected the null hypothesis and accepted the research hypothesis. 
            The findings revealed that central venous catheter infection was less on the 3rd  
day than on the 6th day among the subjects in the experimental group. 
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Figure 5: Comparison of mean central venous catheter infection score of the 
experimental group on the 3
rd
 and 6
th
 day 
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Table 4. 
                Comparison of mean central venous catheter site infection  
score of the control group on 3
rd
 and 6
th
 day. 
                                                                                                      N = 30 
  
            Level of infection                   N            Mean          SD       ‘t value’    
                3rd day                                  30           1.03            1.14           
2.21 * 
                6th day                                  30           1.8              1.03    
  
* Significant at 0.05 level 
                  In order to find out the difference between central venous catheter site  
infections assessment score between on the 3rd and 6th day of the control group, the null  
hypothesis was stated as follows: 
                 Ho2 There will be no significant difference between the central venous  
catheter site infection assessment score on 3rd and 6th day of the control group 
               Table 4 which shows the mean central venous catheter site infection assessment  
score on the 3rd day (1.03) is lower than the central venous catheter site infection  
assessment score on the 6th day (1.8) .The obtained ‘t’ value of 2.21 at degree of  
freedom 29  was significant at 0.05 level. This indicates that the difference between the  
mean is( .77 ) and it was the  true difference and has not occurred by chance. So the 
researcher rejected the null hypothesis and accepted the research hypothesis. 
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Figure 6:  Comparison of mean central venous catheter site infection  score of 
the control group on 3
rd
 and 6
th
 day. 
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Table 5  
            Comparison of mean central venous catheter infection scores of  
experimental and control group on 3
rd
 day  
                                                                                                      N = 60 
  
              Group                                  N            Mean          SD       ‘t value’    
              Experimental   30           0.4              .70           
 3 * 
              Control   30           1.03             1.14    
  
*Significant at 0.05 level 
                In order to find out the difference between central venous catheter site  
infection assessment score of experimental and control group on the 3rd day, the null  
hypothesis was stated as follows: 
               Ho3 the central venous catheter site infection assessment score of the  
experimental group on 3rd day will be significantly lower than the central venous  
catheter site infection assessment score of the control group 
               Table 5 shows that the mean central venous catheter site infection assessment  
score of experimental group on the 3rd day is  (0.4) and it  is lower than the central venous  
catheter site infection assessment score of the control group is (1.03) .The obtained ‘t’  
value of 3 at degree of freedom 58 (2) was significant at 0.05 level. This indicates that  
the difference between the mean is .63and it  was the true difference and has not occurred by 
chance. So the researcher rejected the null hypothesis and accepted the research  
hypothesis. 
              The findings concluded that the central venous catheter site infection on the 3rd  
day was less in subjects who had transparent polyurethane dressing than routine  
  
dressing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6 
        Comparison of mean central venous catheter infection score of  
Experimental and control group on 6
th
 day 
  
                                                                                               N = 60 
  
              Group                                  N            Mean          SD           ‘t value’    
              Experimental                       30           0.9              .90          
4.09* 
              Control                                 30           1.8            1.03    
  
* Significant at 0.05 level 
                In order to find out the difference between central venous catheter site  
infection assessment score of experimental and control group on the 6th day, the null  
hypothesis was stated as follows: 
                Ho4 the central venous catheter site infection assessment score of the  
experimental group on 6th day will  not be significantly lower than the central venous  
catheter site infection assessment score of the control group on 6th day. 
                Table 6 shows  the mean central venous catheter site infection assessment  
score of experimental group on the 6th day is  (0.9)  lower than the central venous  
catheter site infection assessment score of the control group is (1.8) .The obtained ‘t’  
value of 4.09  at degree of freedom 58(2) was significant at 0.05 level. This indicates  
that the difference between the mean is .9 and it was the true difference and has not occurred 
by chance. So the researcher rejected the null hypothesis and accepted the research 
hypothesis.   
 The findings concluded that the central venous catheter site infection on the 6th day was less 
in subjects who had transparent polyurethane dressing than routine dressing. 
  
 
 
  
Table 7 
         Comparison of post mean central venous catheter infection scores of  
experimental and control group for 6 days 
                                                                                               N = 60 
  
           Group                                  N            Mean          SD             ‘t value’    
             
              Experimental                      30           0.56             1.12           2.86* 
              Control                               30           0.73           1.80             3.91*    
  
* Significant at 0.05 level 
                In order to find out the difference between central venous catheter site  
infection assessment score of experimental and control group, the null hypothesis was  
stated as follows: 
                Ho5 The mean post assessment score of the central venous catheter site  
infection in the experimental group will  not be significantly lower than the mean post  
assessment score of the central venous catheter site infection in the control group. 
                Table 6 shows that the mean central venous catheter site infection assessment  
score of experimental group is (0.56) and it is with SD (1.12) and the‘t’ value was 2.86 was 
lower than the mean central venous catheter site infection assessment score (0.73) with SD 
(1.80) on the control group and‘t’ value was 3.91, which is significant at 0.05 level. Since the 
obtained‘t’ value is greater than the table value. So the researcher rejected the null 
hypothesis and accepted the research hypothesis. 
               The findings revealed that the transparent polyurethane (tegaderm) dressing of  
central venous catheter site infection was lower when compared to betadine dressing of  
central venous catheter site infection. 
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Figure7: Comparison of mean central venous catheter infection scores of 
experimental and control group  
 
 
 
 
  
 
SECTION IV 
Table 8 
          Comparison of cost effectiveness of transparent polyurethane dressing  
(tegaderm) and routine dressing among patient with central venous catheter     
  
        Variables       for One Application                   for 6 days Application 
                                          In Rs. /-                                       In Rs. /- 
     
     Tegaderm                  129.50                                            777 
    Betadine                      80.50                                            483 
 
                In order to find out if there is any difference between the cost effectiveness of  
the patients who are using transparent polyurethane (tegaderm) and routine dressing on  
central venous catheter site. 
                Ho6 There will be no significant difference between in terms of cost who has  
received transparent polyurethane (tegaderm) and routine dressing over the central  
venous catheter site. 
              Table 8 shows the cost effectiveness of transparent polyurethane  
(tegaderm) and routine dressing. For one dressing application Rs .129.50 and for 6 days  
application cost is Rs.777 needed for transparent polyurethane (tegaderm). For one day  
betadine application is Rs. 80.50 and for up to 6 days application the cost is Rs .483. 
             The findings revealed that the transparent polyurethane (tegaderm) dressing is  
costly when comparing to routine dressing .The cost difference for one day application  
is Rs.40.  
             The findings revealed that the transparent polyurethane (tegaderm) dressing is  
  
costly when compared to routine dressing 
 
 
 
 
 
129.5
777
80.5
483
0
100
200
300
400
500
600
700
800
900
One day application Six days application
Tegaderm
Betadine
 
Figure 8: Comparison of cost effectiveness of transparent polyurethane dressing 
(tegaderm) and routine dressing among patient with central venous catheter. 
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                                                    CHAPTER V 
                                                     DISCUSSION 
               The aim of the study was to assess the effectiveness of 2% chlorhexidine with 
transparent polyurethane (tegaderm) dressing on preventing infection and cost effectiveness 
among patient with central venous catheter. The experimental approach was used for the 
study. Purposive sampling technique was used to select the samples. A MR VICTOR TOOL 
(Multi Racial Visual Inspection Catheter Tool Observation Record) was used for data 
collection .After data collection, data was organised, tabulated, summarized and analysed. 
The study findings were discussed in this chapter with reference to the objectives of the 
study. 
1. Demographic profile of the sample 
          As per the table no.1-shows that with regard to age, majority of clients 14(46.6%) in 
the experimental group belongs to the age group of 41 – 60 years, whereas 17 (56.6%) in the 
control group belongs to the age group of 41 – 60 years. 
        With regard to sex, in the experimental group 19 (63.3%) were males and 11(36.6%) 
were female’s .In the control group, 20(66.6%) were males and 10(33.3%) were females. 
            With regard to marital status in the experimental group 25 (83.3%) of clients were 
married and 5(16.6%) were unmarried .In the control group, 26 (86.6%) were married and 
4(13.3%) were unmarried. 
            With regard to site of the central venous catheter line, majority of the subjects in the 
experimental group 27 (90%) had internal jugular vein site and 3(10%) of clients  
had subclavian site. In the control group 29 (96.6%) had internal jugular vein site and 
1(3.3%) of the clients had subclavian site. 
  
            With regard to the type of central venous catheter,4(13.3%) of clients had double 
lumen catheter and  26 (86.6%) of the clients had triple lumen catheter in the experimental 
group .In control group, 3(10%) of the clients had double lumen catheter and 27 (90%) of the 
clients had triple lumen catheter . 
                      The above findings are supported by the study in Intensive care unit and related 
research regarding infectious risk associated with central venous catheters conducted in 
Europe. Jean –Christophe Lucet (2010), multicentre randomized two – by two factorial 
design used. The findings revealed that the patient with central venous catheter [n=171] 
under the mean of age 47-74 yrs, 62 clients had colonization (p=0.6), male clients 109 had 
colonization (p=.61). Site of catheter insertion was jugular catheter 67 clients and subclavian 
catheter 36 patients had colonization, p=<.001, double lumen 28 clients and triple lumen 153 
clients had colonization, p=.059. 
2.   The first objective of the study was to assess the level of infection among patient 
with CVC after application of chlorhexidine 2% with transparent polyurethane 
(Tegaderm) and routine dressing on 3
rd
 and 6
th
 day. 
                 As per the table no.-2 with regard to the day wise development of central venous 
catheter site infection of the experimental group majority of the subjects 21(70%) had no 
infection on 3rd day where as in control group only 13 (43.3%) had no infection. with regard 
to the 6th day assessment, in experimental group 11 (36.6%) had no infection, whereas in 
control group only 5(16.6%) had no infection. 
 
              Related to mild infection rate at central venous catheter site, in experimental group 
8(26.6%) had mild infection on 3rd day and 11 (36.6%) had mild infection in control group. 
whereas after application interventions on 6th day 16 (53.3%) had mild infection in 
experimental group and 15 (50%) had mild infection in control group. 
  
             Moderate infection rate was found to be 1(3.3%) in experimental group on 3rd day, 
whereas control group had 6(20%). On the 6th day assessment only least 3 (10%) had 
moderate infection in experimental group, where as 10 (33.3%) had moderate infection in 
control group .None of the subjects in both the groups had severe infection. This difference 
in experimental and control group may be due to the effect of transparent polyurethane 
(tegaderm) dressing.  
3.        The second objective of the study was to assess the effectiveness of 2%  
chlorhexidine with transparent polyurethane (Tegaderm) application in 
terms of preventing infection among patient with CVC on  
experimental group on 3
rd
 and 6
th
 day. 
       Table no.-3 explains the findings with regard to the day wise development of central 
venous catheter site infection of the experimental group assessment score on the 3rd day (o.4) 
with standard deviation (.70) was lesser than the central venous catheter site infection 
assessment score on the 6th day (0.9) with standard deviation (.90) and the‘t’ value was 2.83 
at degree of freedom 29 was significant at 0.05 level. 
          The findings revealed that the central venous catheter site infection on the 3rd day was 
lower than the 6th day of 2% chlorhexidine with transparent polyurethane dressing among 
patients with central venous catheter. 
            The above findings were supported by the prospective randomized study conducted 
by Madeo, Martin and Nobbs (2008). He has done a study to find out the effect of 
transparent polyurethane dressing and sterile gauze dressing at peripheral intravenous 
catheter site. Transparent polyurethane was applied to 49 samples and 31 samples received 
sterile gauze dressing at intravenous catheter site. They have assessed the security of 
fixation, dressing condition, skin condition and rates of inflammation. The mean age of 
  
patients were 63 years and the average length of cannulation was 18 hours. The finding 
showed that the only significant difference between the two groups was the dressing 
condition. The transparent polyurethane group was significantly better (P=0.006) than that of 
the gauze group. 
4. The third objective of the study was to assess the effectiveness of routine 
dressing in terms of preventing infection among patient with CVC on control 
group on 3
rd
 and 6
th
 day. 
       As per the table no. - 4 findings shows that the mean central venous catheter site 
infection assessment score of the control group on the 3rd day (1.03) with standard deviation 
(1.14) was lower than the central venous catheter site infection assessment score on the 6th 
day (1.8) with standard deviation (1.03) and the ‘t’ value of 2.21 at degree of freedom 29 
was significant at 0.05 level.  
         The findings revealed that the central venous catheter site infection on the 3rd day was 
lower than the 6th day of routine betadine dressing among patients with central venous 
catheter. 
          The above findings were supported by randomized multicenter cross over trial study 
conducted by Frasca, Fizelier, Mimoz (2010) conducted a multicenter crossover trial 
compared the effectiveness of two pre-insertion cutaneous antisepsis protocols using 
aqueous 10% povidone-iodine or a solution of 5% povidone iodine in 70% ethanol . The 
incidences of catheter colonization (RR: 0.38 [95% CI: 0.22-0.65]) and catheter-related 
infection (RR: 0.34 [95% CI: 0.13-0.91]) were significantly lower in patients managed using 
the alcoholic povidone iodine solution protocol compared to the aqueous povidone iodine 
solution protocol. No significant effect was observed on bloodstream infections. 
  
5. The fourth objective was to compare the post infection rate among CVC 
patient on experimental and control group in 3
rd
 and 6
th
 day. 
         Table no. -5 shows that the mean central venous catheter site infection assessment 
score of experimental group is (0.56) with SD (1.12) and the‘t’ value was 2.86 was lower 
than the mean central venous catheter site infection assessment score (0.73) with SD (1.80) 
on the control group and ‘t’ value was 3.91, which is significant at 0.05 level. The findings 
revealed that the transparent polyurethane (tegaderm) dressing of central venous catheter site 
infection rate was lower when compared to betadine dressing of central venous catheter site 
infection. 
             The above findings were supported by randomized study Frasca, Fizelier, Mimoz 
(2010) conducted a trial on comparison of chlorhexidine-based solution to 5% alcoholic 
povidone iodine. A total of 538 catheters were randomized and 481 (89.4%) produced 
evaluable culture results. Compared to alcoholic povidone iodine, the use of a chlorhexidine-
based solution significantly reduced the incidence of catheter colonization by 50% (11.6% 
vs. 22.2% p = 0.002; incidence density, 9.7 vs. 18.3 per 1000 catheter-days). The use of the 
chlorhexidine-based solution was also associated with a trend towards the  lower rates of 
catheter-related bloodstream infection (1.7% vs. 4.2% p = 0.09; incidence density, 1.4 vs. 3.4 
per 1000 catheter-days). In this study, independent risk factors for catheter colonization were 
catheter insertion in the jugular vein (RR: 2.01 [95% CI: 1.24-3.24]) and use of alcoholic 
povidone iodine as skin disinfectant (RR: 1.87 [95 CI: 1.18-2.96]). He concluded that 
chlorhexidine-based solutions seem to be more effective than povidone iodine, even in an 
alcoholic formulation, and should be used as first-line antiseptics for CVC care. 
  
6. The fifth objective of the study was to assess and to compare the cost effectiveness of 
transparent polyurethane dressing (Tegaderm) and routine dressing among patient 
with central venous catheter. 
           Table no.-8 shows that the cost effectiveness of transparent polyurethane (tegaderm) 
and routine dressing. For one dressing application Rs .129.50 and for 6 days application 
Rs.777 was needed for transparent polyurethane (tegaderm). For one day betadine 
application Rs. 80.50 and for up to 6 days application cost is Rs .483 was needed. 
             The findings revealed that the transparent polyurethane (tegaderm) dressing is costly 
when compared to routine dressing .The cost difference for one day application is Rs.40.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                           CHAPTER VI 
            Summary, Conclusion, Implication and   Recommendation 
            This chapter includes the summary, conclusion and implication of the  
study in the field of nursing. It also presents the recommendations for the future  
research. 
                             Summary of the study 
The aim of the study was to evaluate the effectiveness of 2% chlorhexidine with  
transparent polyurethane (tegaderm) dressing on preventing infection and cost  
effectiveness among patient with central venous Catheter. 
The following objectives were set for the study  
1. To assess the level of infection among patient with Central Venous Catheter 
after application of chlorhexidine 2% with transparent polyurethane 
(Tegaderm) and routine dressing on 3rd and 6th day. 
2. To assess the effectiveness of transparent polyurethane (Tegaderm) application 
in terms of preventing infection among patient with Central Venous Catheter on 
experimental group on 3rd and 6th day. 
3. To assess the effectiveness of routine dressing in terms of preventing infection 
among patient with Central Venous Catheter on control group on 3rd and 6th day. 
4. To compare the post infection rate among Central Venous Catheter patient on 
experimental and control group in 3rd and 6th day. 
5. To compare the cost effectiveness of transparent polyurethane dressing 
(Tegaderm) and routine dressing among patient with Central Venous Catheter. 
The following hypotheses were tested at 0.05  level of significance. 
  
1.  There will be significant difference between the Central Venous Catheter site 
infection assessment score on the 3rd and 6th day of the experimental group. 
2.  There will be significant difference between the Central Venous Catheter site 
infection assessment score on 3rd and 6th day of the control group. 
3. The mean post infection assessment score of patient with Central Venous Catheter 
who had  2% chlorhexidine with  transparent polyurethane (Tegaderm) dressing will 
be significantly lower than the mean infection assessment score of patient with 
Central Venous Catheter who had  routine dressing on day 3 & 6th day. 
4. There will be significant difference in terms of cost who has received Tegaderm 
and routine treatment over the Central Venous Catheter site. 
                The experimental research approach was used for the study .The design 
adopted was post –test only quasi experimental design. The study was conducted in 
Shenbagum hospital, Madurai which has 125 beds and 1 kilometre away from Sacred 
Heart Nursing College and Apollo hospital, Madurai which has 250 beds and ½ 
kilometres away from Sacred Heart Nursing College. Purposive sampling technique 
was used to select the samples. A total number of 60 samples were selected and 
among those 30 samples were treated with 2% chlorhexidine with transparent 
polyurethane (tegaderm) and 30 samples were treated with betadine dressing. A 
standardized MR VICTOR TOOL (Multi Racial Visual Inspection Catheter Tool 
Observation Record) grading system was used for data collection. Data collection 
procedure was used for a period of six weeks. After data collection, data was 
organized, tabulated, summarized and analyzed. 
 
  
                                         Major findings of the study  
1. With regard to age, majority of clients 14(46.6%) in the experimental group belongs to the 
age group of 41 – 60 years, whereas 17 (56.6%) in the control group belongs to the age 
group of 41 – 60 years. 
  2. With regard to sex, in the experimental group 19 (63.3%) were males and 11(36.6%) 
were female’s .In the control group, 20(66.6%) were males and 10(33.3%) were females. 
3. With regard to marital status in the experimental group 25 (83.3%) of clients were married 
and 5(16.6%) were unmarried .In the control group, 26 (86.6%) were married and 4(13.3%) 
were unmarried. 
 4. With regard to site of the central venous catheter line, majority of the subjects in the 
experimental group 27 (90%) had internal jugular vein site and 3(10%) of the clients had 
subclavian site. In the control group 29 (96.6%) had internal jugular vein site and 1(3.3%) of 
the clients had subclavian site. 
5. With regard to the type of central venous catheter, 4(13.3%) of the clients had double 
lumen catheter and 26 (86.6%) of the clients had triple lumen catheter in the experimental 
group .In control group, 3(10%) of the clients had double lumen catheter and 27 (90%) of the 
clients had triple lumen catheter. 
6. Distribution of central venous catheter site infection among the experimental group and 
control group showed that the 1(3.3%) had moderate infection on 3rd day in experimental 
group where as in control group 6(20%) had the moderate infection. 3(10%) had moderate 
infection on 6th day in experimental group where as in control group 10(33.3%) had the 
moderate infection. 
7. The mean central venous catheter site infection score of experimental group on 3rd day 
(0.4) was lower than the 6th day (0.9). 
  
8. The mean central venous catheter site infection score of control group on 3rd day (1.03) 
was lower than the 6th day (1.8). 
9. The mean central venous catheter site infection score of the experimental group on the 3rd 
day (0.4) was lower than the control group on the 3rd day (1.03). 
10. The mean central venous catheter site infection score of the experimental group on the 6th 
day (0.9) was lower than the control group on the 6th day (1.8). 
11. The mean central venous catheter site infection score of the experimental group (0.56) 
was lower than the control group (0.73). 
12. The cost effectiveness of transparent polyurethane (tegaderm) for one application was Rs 
.129.50 and routine betadine dressing was Rs.80.50 .The tegaderm dressing was costly when 
compared to the betadine dressing. 
 
 
 
                                                      
 
 
 
 
 
 
 
 
 
  
                                                    Conclusion 
1. Transparent polyurethane (tegaderm) dressing was to be effective in reducing the 
central venous catheter site infection among patient with central venous catheter. 
2. There was a significant difference between the Central venous catheter site 
infection assessment score on the 3rd and 6th day of the transparent polyurethane 
(tegaderm) dressing 
3. There was a significant difference between the Central venous catheter site 
infection assessment score on 3rd and 6th day of the routine betadine dressing. 
4. The mean post central venous catheter infection assessment score of the 
experimental group was significantly lower than the control group after application of 
transparent polyurethane (tegaderm) and betadine dressing.  
  5. Tegaderm dressing was costly when compared to the betadine dressing. 
Implications 
 The findings of the study have practical application in the field of nursing. The 
implication of the study could be discussed in four areas mainly nursing practice, 
nursing administration, nursing education and nursing research. 
Implications for Nursing Practice: 
      The findings of the study will help the nurses in the following ways. 
1. Early identification and prevention of the complication of central venous 
catheter site. 
2. As 2 %chlorhexidine with transparent polyurethane (tegaderm) dressing is an 
expensive , and has minimal side effects , nurses can use for central venous 
  
catheter care ,to prevent central venous catheter site infection of patient with 
central venous catheter. 
3. Nurses can use easily MR VICTOR scale for early identification of the 
infection at central venous catheter site. 
4. More nursing study can be conducted on central venous catheter site infection 
assessment in order to select proper cleaning solution. 
Implications for Nursing Education: 
1. This study enhances the nursing students to acquire knowledge, assessment of 
central venous catheter infection and prevention of central venous catheter 
infection. 
2. This study enhances the student to think comprehensively in planning for the 
intervention in prevention of central venous catheter infection. 
3. This study enables the students to compare the other possible ways of prevention 
of central venous catheter infection. 
4. This study arouses motivation on the student to intelligibility care for the clients 
with central venous catheter. 
5. The findings would help nursing faculty to give importance for using appropriate 
assessment and cleaning the central venous catheter site properly. 
Implication for Nursing Research: 
1. This study motivates for further studies related to this field. 
2. This study will help the researcher to formulate new dressing methods to prevent 
central venous catheter infection. 
3. This study can be a baseline for further studies to build upon. 
  
Implication for Nursing Administration: 
               1. It helps to provide critical thinking regarding central venous catheter and               
its management. 
 2. The nurse advocate can arrange for continuing education programme for the 
nursing personnel to update their knowledge in assessing and care for patients with 
central venous catheter. 
   3. Standard protocol can be formulated for the prevention of central venous catheter 
infection by selecting appropriate cleansing agent at central venous catheter site. 
 4. The nurse administrator can bring a policy change regarding the central venous 
catheter care for prevention of central venous catheter infection  
5. The nurse administrator can arrange seminars, conference and workshop to 
educate head nurses and staff nurses regarding the importance of central venous 
catheter care. 
 
 
                                        Limitations 
1. The sample sizes in the experimental and in control group were 30. Hence the 
findings should be generalized with caution. 
2. The patients were followed only for 6 days. 
3. The frequency of dressing was once a day. 
 
                                  
 
 
 
  
Recommendations 
1. A similar study can be conducted on a large sample to generalize the study 
findings. 
2. An explorative study can be done at various settings to identify factors influence 
the central venous catheter site infections. 
3. Longitudinal study can be done to find out the occurrence of all central venous 
catheter site infection of patients with central venous catheter. 
4. A study can be conducted to evaluate the knowledge and the attitude of nurses 
regarding central venous catheter site care. 
5. A comparative study can be done to find the incidence of central venous catheter 
site infection among different types of central venous catheter. 
6. Infection rate of central venous catheter site can be studied among various 
populations. 
7. Comparative study can be done to find out the incidence of central venous 
catheter site infection among patients receiving chemotherapy with patients in 
other wards. 
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college has to conduct a Research project, which is to be submitted to The Tamilnadu Dr. 
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 The topic of research project is “A study to assess the effectiveness of chlorhexidine 
2% with transparent polyurethane (tegaderm) dressing on preventing infection and cost 
effectiveness among patient with central venous catheter in selected Hospital at Madurai. 
We therefore request you to kindly permit her to do the research work in your hospital 
under your valuable guidance and suggestions.  
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                         Principal 
         SACRED HEART NURSING COLLEGE  
 
  
 
 
 
                                            
  
                                           APPENDIX –II 
 
Letter requesting options and suggestions of experts for establishing content validity 
and validity of tool        
  From  
        C.Regila Jasmine, 
         Msc (N) 2nd year, 
         Sacred Heart Nursing College, 
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  To,            
           
Respected Sir/Madam                     
SUB  :  Requesting and suggestion of experts for the content validity and validity of tool. 
Iam a post graduate student (Medical SurgicalSpeciality) of The Sacred Heart Nursing 
College. I have selected the below mentioned topic of the research project submitted to 
DR.M.G.R. Medical university, Chennai as a fulfilment of Master of Science in nursing.   
 TITLE OF THE TOPIC:       
                         “A study to assess the effectiveness of chlorhexidine 2% with transparent 
polyurethane (tegaderm) dressing on preventing infection and cost effectiveness among 
patient with central venous catheter in selected Hospital at Madurai” 
 With regard to this may I kindly request you to content and validate my tool for its 
relevancy. Iam enclosing the objectives of the study. I would be highly obliged and remain 
thankful for your great if you could validate and send it as early as possible.    
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Place :        Your’s faithfully,  
 Date  :          (C.Regila Jasmine) 
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APPENDIX – IV 
                                              MR VICTOR TOOL 
(Multi Racial Visual Inspection Catheter Tool Observation Record) 
    To Score the patients CVC exit site the nurse needs to place the individual chart 
against the patients exit site.  Comparing the images against the patient a score can 
then be allocated.  Scoring is from 0-4, 0 being no signs of infection and 4 being 
severe of infection.  When the score has been decided it is then recorded on the 
relevant record chart. 
               
 
Day 3 
           
Day 6 
 
 
Scoring sheet  
 
 
Signs / 
Symptoms 
P A Interpretation P  A  Interpretati
on 
No Fever,  
No discharge,  
Dry & Clean 
wound 
      
Mild fever 
 
 
 
 
Mild serum 
discharge 
      
Fever 
Pus wound 
(or) 
Serum 
Discharge 
 
      
 
Catheter 
blockage 
Catheter tip  
culture positive, 
      
KEY WORDS :P=PRESENT   A= ABSENT 
 
  
 
DEMOGRAPHIC DATA 
 
Information Related to Patient 
 
1. Name    :  
 
2. Age (In years)   : a) Below 20 
      b) 21 – 40 
      c) 41 – 60 
      d) 61 – 80 
       
3. Gender     : a) Male 
      b) Female 
 
4. Marital Status   : a) Married 
      b) Unmarried  
 
5. Site of CVC Line   : 
 
6. Type of CVC Line  : 
 
 
 
 
 
 
 
 
 
  
                                               APPENDIX  - V 
               DRESSING PROCEDURE FOR CLEANSING CVC SITE 
ARTICLES 
A Sterile tray containing 
   S.NO  
                  ARTICLES 
 
               PURPOSES 
     1 Gloves, mask  To prevent infection 
      2 Gauze pieces To clean and dress the wound 
      3 Cleansing  solutions 
Chlorhexidine        (2%) 
Betadine solution  (5%) 
To clean the wound and the 
surrounding skin area 
     4 Small bowls  To take the cleansing solutions 
     5 Scissors  To cut the gauze pieces to fit around 
the wound  
    6 Artery forceps To clean the wound 
    7 Dressing towel  To clean the wound and the 
surrounding skin area 
   8 Transparent polyurethane 
(tegaderm) 
To apply on the central venous catheter 
site 
   9 Adhesive plaster To fix the dressing in place 
   10 Kidney tray To collect the waste 
    11 Mackintosh and towel To protect the bed garments 
 
  
PRELIMINARIES: 
 Check the diagnosis and general condition of the patient. 
 Check the condition of the CVC site, signs and exudates amount. 
 Check the patient’s name, bed number and other identification. 
 Check the abilities and limitation of  the patient 
 Check the consciousness of the patient 
 Check the articles available in the unit 
PROCEDURE: 
S.NO.                              STEPS      RATIONALE 
    1   Tie the mask To prevent wound contamination 
    2 Wash hands thoroughly for 15sec with 
liquid antimicrobial solution 
To prevent cross infection 
    3 Put on clean gloves  To ensure asepsis 
    4 Carefully loosen and remove the old 
dressing. Peel the dressing toward the 
site without pulling on the CVC 
To prevent contamination and to get 
ready for sterile dressing 
 
   5 Inspect the area around the site for any 
signs of infection by using  
MR VICTOR Tool. 
To assess the wound infection status 
    6 Wash hands again for 15 sec with 
liquid antibacterial soap. Dry hands 
with towels  
To prevent cross infection 
  
    7 Open the sterile dressing  tray To get ready to apply the dressing 
    8 Cleanse the area with solution for 30 
sec and allow  the area to dry for 30sec 
To keep the wound clean 
    9 For experimental group: 
    Clean the site with  2% 
chlorhexidine then application of  
transparent polyurethane (tegaderm) 
dressing. 
 
For Control group: 
    Clean the CVC site with  betadine 
solution .Then apply the gauze which is 
soaked in betadine solution. 
 
It is a powerful, non irritating 
antiseptic solution. Tegaderm 
dressing helps to visualize the 
wound easily and protect the 
catheter site from external 
contamination.  
 
It is a microbial agent and helps in 
reduction of central venous catheter 
site infection.                   - 
   10 Remove the gloves and discard it  Gloves worn during the dressing 
adhesive plaster will be highly 
contaminated the CVC site 
    11 Secure the dressing with adhesive 
plaster. 
 
                      - 
 
 
 
 
